FeesSafety
Pluang+

Bitcoin Core fixes medium-severity bug causing crashes on Windows and macOS nodes.

Protocol Fundamentals
29 Oct 2026, 00:25 WIB
Crypto Briefing
View Source
Neutral
Bitcoin Core fixes medium-severity bug causing crashes on Windows and macOS nodes.

Bitcoin Core disclosed a medium-severity vulnerability affecting Windows and macOS nodes that allows attackers to crash nodes by exhausting memory through TCP urgent data floods. The flaw exploits differences in socket monitoring, causing unbounded memory growth and node crashes, which disrupt transaction validation and relay until restarted. The issue was fixed promptly in Bitcoin Core versions 29.5, 30.4, 31.2, and 32.1, with users urged to update immediately to avoid operational interruptions. No CVEs were assigned, marking a shift in Bitcoin Core's disclosure approach, and the vulnerability was found using advanced machine learning code scanning tools.

Bitcoin Core's recent vulnerability disclosure comes as 43 out of 50 major cryptocurrencies on Pluang rose today. For readers following the broader crypto market, here is Pluang's snapshot as of Oct 29, 2026 03:33 WIB: LINK was priced at Rp213.435 with a 1-day change of +2.67% and Pluang order activity showing 65% Sell / 35% Buy; XNO stood at Rp6.179, up 2.66%, with 96% Sell / 4% Buy order activity; CRV traded at Rp6.255, rising 2.49%, with 3% Sell / 97% Buy order activity.

More News

China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market is projected to grow from $5.8 billion in 2026 to $8.04 billion by 2032, at a CAGR of 5.54%. Growth is fueled by expanding chain cafes, specialty coffee methods like cold brew, and rising homegrown brands. However, rising coffee...

Market News
Neutral
20 minutes ago
FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

HUTCHMED announced that the US FDA has granted orphan drug designation to sovleplenib for treating primary immune thrombocytopenia (ITP), a rare autoimmune disorder causing low platelet counts and bleeding risks. This status provides benefits like 7 ...

Market News
Bullish
20 minutes ago
LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED held a global media test drive event at Chery's International Headquarters in Vu Hồ, featuring the luxury MPV LLounge and the high-performance Stormax SUV. Media representatives and influencers from UAE, Thailand, and Indonesia experienced a 1...

Market News
Bullish
20 minutes ago
Law firm investigates NVE Corporation over sharp Q2 revenue drop and stock plunge.

Law firm investigates NVE Corporation over sharp Q2 revenue drop and stock plunge.

Kirby McInerney LLP is investigating NVE Corporation for possible violations of federal securities laws after the company reported a 47% revenue decline and a 33.7% stock price drop following its Q2 fiscal 2027 results. The revenue fall was attribute...

Market News
Bearish
2 hours ago
Fort Technology warned by Nasdaq for falling below $1 minimum bid price, given 180 days to comply.

Fort Technology warned by Nasdaq for falling below $1 minimum bid price, given 180 days to comply.

Fort Technology received a notification from Nasdaq on October 13, 2026, stating it failed to meet the minimum bid price requirement of $1.00 per share over the past 30 days. The company has 180 days, until April 12, 2027, to restore its share price ...

Market News
Bearish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App